Okolo P I, Pasricha P J, Kalloo A N
Division of Gastroenterology, The Johns Hopkins Hospital, Baltimore, MD 21205, USA.
Gastrointest Endosc. 2000 Jul;52(1):15-9. doi: 10.1067/mge.2000.106669.
Endoscopic pancreatic sphincterotomy has been touted as effective therapy for chronic pancreatitis and unexplained abdominal pain resulting from pancreatic sphincter dysfunction. Although short-term data are encouraging, there are no reports on how these patients fare beyond the first few months.
We performed a retrospective review of records on all patients who had pancreatic sphincterotomy during a 4-year period between August 1992 and November 1996. Chronic pancreatitis was diagnosed by pancreatography. Patients were evaluated for symptomatic response to pancreatic sphincterotomy and clinical improvement was defined as greater than 50% reduction in the magnitude of pain.
Fifty-five patients had pancreatic sphincterotomy including patients with (n = 40) and without (n = 15) chronic pancreatitis. After a median follow-up of 16 months, 60% of all patients reported improvement of pain scores (3.6 +/- 3.4 vs. 8.8 +/- 1.8; p < 0.01) with the best response in patients without evidence of chronic pancreatitis. Complications of pancreatic sphincterotomy included pancreatitis in 5 patients (9%), bleeding in 2 (3.6%) and early stent occlusion in 5 patients (9%). There were no deaths.
In a subgroup of patients with pancreatic sphincter dysfunction, endoscopic pancreatic sphincterotomy results in significant sustained clinical improvement.
内镜下胰管括约肌切开术被认为是治疗慢性胰腺炎以及由胰管括约肌功能障碍引起的不明原因腹痛的有效方法。尽管短期数据令人鼓舞,但尚无关于这些患者在最初几个月后的病情发展情况的报道。
我们对1992年8月至1996年11月这4年间所有接受胰管括约肌切开术的患者的记录进行了回顾性研究。慢性胰腺炎通过胰管造影术诊断。评估患者对胰管括约肌切开术的症状反应,临床改善定义为疼痛程度减轻超过50%。
55例患者接受了胰管括约肌切开术,其中包括患有慢性胰腺炎的患者(n = 40)和未患慢性胰腺炎的患者(n = 15)。中位随访16个月后,所有患者中有60%报告疼痛评分有所改善(3.6±3.4对8.8±1.8;p < 0.01),在无慢性胰腺炎证据的患者中反应最佳。胰管括约肌切开术的并发症包括5例胰腺炎(9%)、2例出血(3.6%)和5例早期支架堵塞(9%)。无死亡病例。
在一部分胰管括约肌功能障碍患者中,内镜下胰管括约肌切开术可带来显著且持续的临床改善。